APPLICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION

被引:0
|
作者
DPLu
NLGuo
XJHuang
JZhang
YMFan
QShi
BJiang
机构
[1] InstituteofHematology
[2] BeijingMedicalUniversityBeijing100044
关键词
BMT; APPLICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR; FILGRASTIM;
D O I
暂无
中图分类号
R733.7 [白血病];
学科分类号
100214 ;
摘要
The effect of rhG-CSF (Filgrastim by Amgen Co.as Neupogen and Kirin Co.as Gran) was evaluated in 20 patients with leukemia after allogeneic
引用
收藏
页码:19 / 20
页数:2
相关论文
共 50 条
  • [41] Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation
    Lee, KH
    Lee, JH
    Choi, SJ
    Kim, S
    Lee, JS
    Kim, SH
    Kim, WK
    BONE MARROW TRANSPLANTATION, 1999, 24 (06) : 591 - 599
  • [42] Hematologic effects of subcutaneous administration of recombinant human granulocyte colony-stimulating factor (filgrastim) in healthy alpacas
    McKenzie, Erica C.
    Tornquist, Susan J.
    Gorman, M. Elena
    Cebra, Christopher K.
    Payton, Mark E.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2008, 69 (06) : 770 - 776
  • [43] Recombinant granulocyte colony-stimulating factor (filgrastim): Optimization of conjugation conditions with polyethylene glycol
    I. A. Puchkov
    N. V. Kononova
    A. I. Bobruskin
    D. I. Bairamashvili
    V. A. Mart’yanov
    A. M. Shuster
    Russian Journal of Bioorganic Chemistry, 2012, 38 : 479 - 487
  • [44] Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation
    K-H Lee
    J-H Lee
    S-J Choi
    S Kim
    J-S Lee
    S-H Kim
    W-K Kim
    Bone Marrow Transplantation, 1999, 24 : 591 - 599
  • [45] Recombinant granulocyte colony-stimulating factor (filgrastim): Optimization of conjugation conditions with polyethylene glycol
    Puchkov, I. A.
    Kononova, N. V.
    Bobruskin, A. I.
    Bairamashvili, D. I.
    Mart'yanov, V. A.
    Shuster, A. M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2012, 38 (05) : 479 - 487
  • [46] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS THE BEAM REGIMEN INSTEAD OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    FOUILLARD, L
    GORIN, NC
    LAPORTE, JP
    DOUAY, L
    ISNARD, F
    NAJMAN, A
    LANCET, 1989, 1 (8652): : 1460 - 1460
  • [47] A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation
    Kröger, N
    Renges, H
    Krüger, W
    Gutensohn, K
    Löliger, C
    Carrero, I
    Cortes, L
    Zander, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (03) : 761 - 765
  • [48] Donor treatment with recombinant human interleukin-11 and recombinant human granulocyte colony-stimulating factor preserves the graft-versus-leukaemia effects after allogeneic bone marrow transplantation
    Huang, X. J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S171 - S171
  • [49] CLINICAL EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
    TESHIMA, H
    SHIBATA, H
    HIRAOKA, A
    NAKAMURA, H
    MASAOKA, T
    TAKAKU, F
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 520 - 520
  • [50] RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID CANCER
    NEMUNAITIS, J
    RABINOWE, SN
    SINGER, JW
    BIERMAN, PJ
    VOSE, JM
    FREEDMAN, AS
    ONETTO, N
    GILLIS, S
    OETTE, D
    GOLD, M
    BUCKNER, CD
    HANSEN, JA
    RITZ, J
    APPELBAUM, FR
    ARMITAGE, JO
    NADLER, LM
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (25): : 1773 - 1778